Levitee Labs Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVTTF research report →
Price Chart
About the company
Levitee Labs Inc. is a holistic wellness enterprise dedicated to providing advanced, evidence-backed alternative treatments, including innovative psychedelic therapies. The company's operations are structured into two primary divisions: Medical Services and Product Sales.
- CEO
- David Bentil
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Get TickerSpark's AI analysis on LVTTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $369.15K
- P/E
- -0.03
- PEG
- 0.00
- P/S
- 0.29
- P/B
- 0.04
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
- Gross Margin
- 39.95%
- Op Margin
- -638.70%
- Net Margin
- -662.39%
- ROE
- -258.68%
- ROIC
- -105.71%
Latest fiscal year · YoY change
- Revenue
- $1.72M+0.0%
- Gross Profit
- $687.64K+0.0%
- Op Income
- $-11,743,092
- Net Income
- $-11,402,682-2481.4%
- EPS
- $-0.27-4809.1%
- OCF Growth
- -2804.6%
- FCF Growth
- -3766.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.28
- RSI (14)
- 53
- Avg Volume
- 64
No earnings-call transcripts are available for LVTTF yet.
- Free Float
- 99.9%
- Shares Outstanding
- 136.72M
- Float Shares
- 136.64M
Our LVTTF coverage
Recent articles, reports, and earnings notes.
No research on LVTTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LVTTF report →CSE Bulletin: Delist - Levitee Labs Inc. (LVT)
newsfilecorp.com · Jan 26
Levitee Labs announces completion of Earth Circle sale; amends financing terms with RiverFort Global Opportunities
proactiveinvestors.com · Sep 19
Levitee Labs appoints economist David Bentil as chief executive officer
proactiveinvestors.com · Jun 21
Levitee Labs appoints Philip van den Berg as its new interim CEO; closes first tranche of its private placement
proactiveinvestors.com · Feb 1
Levitee Labs announces non-brokered private placement of up to C$3M
proactiveinvestors.com · Jan 19
Levitee Labs inks retail distribution agreement with Body Energy Club for MONKE Nutraceuticals
proactiveinvestors.com · Jan 12
Levitee Labs Teams Up With Canntab Therapeutics, Offer Cannabinoid Products As Alternatives To Opioids
benzinga.com · Jan 10
Levitee Labs partners with Canntab Therapeutics to provide alternative to drugs amid opioid crisis in Canada
proactiveinvestors.com · Jan 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.